Jeffrey B. Sherman

587 total citations
9 papers, 446 citations indexed

About

Jeffrey B. Sherman is a scholar working on Rheumatology, Clinical Biochemistry and Molecular Biology. According to data from OpenAlex, Jeffrey B. Sherman has authored 9 papers receiving a total of 446 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Rheumatology, 6 papers in Clinical Biochemistry and 4 papers in Molecular Biology. Recurrent topics in Jeffrey B. Sherman's work include Glycogen Storage Diseases and Myoclonus (6 papers), Metabolism and Genetic Disorders (6 papers) and Genetic Syndromes and Imprinting (3 papers). Jeffrey B. Sherman is often cited by papers focused on Glycogen Storage Diseases and Myoclonus (6 papers), Metabolism and Genetic Disorders (6 papers) and Genetic Syndromes and Imprinting (3 papers). Jeffrey B. Sherman collaborates with scholars based in United States, Japan and Israel. Jeffrey B. Sherman's co-authors include Paul H. Plötz, Nina Raben, Frederick W. Miller, Elizabeth M. Adams, Richard L. Leff, Mark F. Gourley, Jeanne E. Hicks, Zohar Argov, Roland Spiegel and Hideaki Nakajima and has published in prestigious journals such as Journal of Biological Chemistry, Neurology and Muscle & Nerve.

In The Last Decade

Jeffrey B. Sherman

9 papers receiving 426 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jeffrey B. Sherman United States	8	247	224	128	82	66	9	446
R. Tsuburaya Japan	9	141 0.6×	271 1.2×	180 1.4×	72 0.9×	12 0.2×	19	434
Mei Zong Sweden	8	93 0.4×	294 1.3×	144 1.1×	42 0.5×	16 0.2×	10	420
Yawen Zhao China	10	76 0.3×	132 0.6×	135 1.1×	46 0.6×	33 0.5×	45	331
Osvaldo H. Perurena United States	6	218 0.9×	356 1.6×	122 1.0×	123 1.5×	4 0.1×	8	483
Wladimir Mauhin France	9	61 0.2×	194 0.9×	118 0.9×	36 0.4×	5 0.1×	22	356
Brianne H. Daniels United States	8	59 0.2×	132 0.6×	133 1.0×	34 0.4×	3 0.0×	9	317
Christiane Bay Denmark	11	11 0.0×	95 0.4×	150 1.2×	24 0.3×	26 0.4×	21	477
B Arnaud France	10	15 0.1×	36 0.2×	129 1.0×	30 0.4×	15 0.2×	37	381
Kim K. Creus Belgium	11	66 0.3×	187 0.8×	192 1.5×	34 0.4×		15	368
Wolfram Henn Germany	12	80 0.3×	117 0.5×	190 1.5×	89 1.1×	2 0.0×	27	540

Countries citing papers authored by Jeffrey B. Sherman

Since Specialization

Citations

This map shows the geographic impact of Jeffrey B. Sherman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jeffrey B. Sherman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jeffrey B. Sherman more than expected).

Fields of papers citing papers by Jeffrey B. Sherman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jeffrey B. Sherman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jeffrey B. Sherman. The network helps show where Jeffrey B. Sherman may publish in the future.

Co-authorship network of co-authors of Jeffrey B. Sherman

This figure shows the co-authorship network connecting the top 25 collaborators of Jeffrey B. Sherman. A scholar is included among the top collaborators of Jeffrey B. Sherman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jeffrey B. Sherman. Jeffrey B. Sherman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Adams, Elizabeth M., et al.. (1998). Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens. Arthritis & Rheumatism. 41(3). 392–399. 120 indexed citations

Hicks, Jeanne E., Elizabeth M. Adams, Jeffrey B. Sherman, et al.. (1998). Treatment of refractory myositis: A randomized crossover study of two new cytotoxic regimens. Arthritis & Rheumatism. 41(3). 392–399. 101 indexed citations

Raben, Nina, Jeffrey B. Sherman, Elizabeth M. Adams, et al.. (1995). Various classes of mutations in patients with phosphofructokinase deficiency (Tarui's disease). Muscle & Nerve. 18(S14). S35–S38. 4 indexed citations

Raben, Nina & Jeffrey B. Sherman. (1995). Mutations in muscle phosphofructokinase gene. Human Mutation. 6(1). 1–6. 34 indexed citations

Raben, Nina, Roland Spiegel, Jeffrey B. Sherman, et al.. (1995). Functional expression of human mutant phosphofructokinase in yeast: genetic defects in French Canadian and Swiss patients with phosphofructokinase deficiency.. PubMed. 56(1). 131–41. 57 indexed citations

Sherman, Jeffrey B., Nina Raben, Zohar Argov, et al.. (1994). Common mutations in the phosphofructokinase-M gene in Ashkenazi Jewish patients with glycogenesis VII--and their population frequency.. PubMed. 55(2). 305–13. 53 indexed citations

Argov, Zohar, V. Barash, Daniel Soffer, Jeffrey B. Sherman, & Nina Raben. (1994). Late‐onset muscular weakness in phosphofructokinase deficiency due to exon 5/intron 5 junction point mutation. Neurology. 44(6). 1097–1097. 14 indexed citations

Raben, Nina, et al.. (1993). A 5' splice junction mutation leading to exon deletion in an Ashkenazic Jewish family with phosphofructokinase deficiency (Tarui disease).. Journal of Biological Chemistry. 268(7). 4963–4967. 44 indexed citations

Calderon, Tina M., et al.. (1992). Interleukin 6 modulates c-sis gene expression in cultured human endothelial cells. Cellular Immunology. 143(1). 118–126. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact